18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Natural Killer/T-cell Lymphoma
Condition(s):Lymphoma, Extranodal NK-T-CellLast Updated:February 13, 2017Unknown status
Hide Studies Not Open or Pending
Condition(s):Lymphoma, Extranodal NK-T-CellLast Updated:February 13, 2017Unknown status
Condition(s):Lymphoma, Extranodal NK-T-CellLast Updated:February 13, 2017Unknown status
Condition(s):Lymphoma, Extranodal NK-T-CellLast Updated:April 20, 2016Unknown status
Condition(s):Lymphoma, Extranodal NK-T-CellLast Updated:May 9, 2018Terminated
Condition(s):Lymphoma, Extranodal NK-T-CellLast Updated:May 22, 2023Recruiting
Condition(s):Lymphoma, Extranodal NK-T-CellLast Updated:September 24, 2021Unknown status
Condition(s):Lymphoma, Extranodal NK-T-CellLast Updated:November 8, 2017Unknown status
Condition(s):Lymphoma, Extranodal NK-T-CellLast Updated:May 9, 2018Terminated
Condition(s):Lymphoma, Extranodal NK-T-CellLast Updated:December 24, 2013Unknown status
Condition(s):Lymphoma, Extranodal NK-T-Cell; EBVLast Updated:August 25, 2016Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.